Start free

Company Layoffs & Restructurings, Week of Aug 3, 2026: 8-K Filings

In the week of Aug 3, 2026 to Aug 9, 2026, 6 companies disclosed a workforce reduction or restructuring plan in 6 SEC filings (8-K Item 2.05 or the company's own announcement), according to EquiReason's reading of the filings.

Source: SEC EDGAR filings · Aug 3, 2026 – Aug 9, 2026 · read by EquiReason

DateCompanyFilingWhat the filing reports
2026-08-07GFF Griffon Corporation8-K · 8.01, 9.01Recast financials to reflect discontinued operations from AMES North America JV, AMES Australasia sale, and AMES UK liquidation. Company now one reportable segment. Strategic exit from non-core businesses.
2026-08-07ATYR aTyr Pharma, Inc.8-K · 2.02, 9.01aTyr Pharma announces 60% workforce reduction, CFO and GC departures, to reduce annualized opex by ~$13M. Focuses on efzofitimod ILD program; cash runway into late 2028.
2026-08-06NRDY Nerdy Inc.8-K · 2.05Nerdy Inc. committed to wind down its Varsity Tutors for Schools business line, with estimated exit-related costs of $2M-$4M, including severance, contract termination, and asset impairment charges.
2026-08-05CHYM Chime Financial, Inc.8-K · 2.02, 2.05, 5.02, 9.01—
2026-08-04NTNX Nutanix, Inc.8-K · 2.05Nutanix announced a 5% workforce reduction with estimated pre-tax charges of $33M-$43M, primarily severance costs, to streamline operations and reallocate resources to strategic priorities.
2026-08-04BIO Bio-Rad Laboratories, Inc.8-K · 2.02, 2.05, 7.01, 9.01Bio-Rad initiates restructuring plan with $80-90M pre-tax charges, including layoffs and facility closures, to improve operating performance.

Questions

Which companies announced layoffs in the week of aug 3, 2026?
Griffon Corporation (GFF), aTyr Pharma, Inc. (ATYR), Nerdy Inc. (NRDY), Chime Financial, Inc. (CHYM), Nutanix, Inc. (NTNX), Bio-Rad Laboratories, Inc. (BIO) — the full list, with dates and the filing behind each row, is above.

Earlier weeks

2026 W43 · 2026 W42 · 2026 W41 · 2026 W40 · 2026 W39 · 2026 W38 · 2026 W37 · 2026 W36 · 2026 W35 · 2026 W34 · 2026 W33 · 2026 W32 · Other lists: Guidance raised or cut · Insider buying · Executive and board changes · Mergers and acquisitions · Stock buybacks announced

How these figures are read: methodology · EquiReason.